ID   PCAY_PSEPK              Reviewed;         550 AA.
AC   Q88JK6;
DT   23-FEB-2022, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2003, sequence version 1.
DT   05-FEB-2025, entry version 113.
DE   RecName: Full=Methyl-accepting chemotaxis protein PcaY {ECO:0000305};
DE   AltName: Full=PcaY_PP {ECO:0000303|PubMed:28620365};
GN   Name=pcaY {ECO:0000303|PubMed:12534463};
GN   OrderedLocusNames=PP_2643 {ECO:0000312|EMBL:AAN68251.1};
OS   Pseudomonas putida (strain ATCC 47054 / DSM 6125 / CFBP 8728 / NCIMB 11950
OS   / KT2440).
OC   Bacteria; Pseudomonadota; Gammaproteobacteria; Pseudomonadales;
OC   Pseudomonadaceae; Pseudomonas.
OX   NCBI_TaxID=160488;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 47054 / DSM 6125 / CFBP 8728 / NCIMB 11950 / KT2440;
RX   PubMed=12534463; DOI=10.1046/j.1462-2920.2002.00366.x;
RA   Nelson K.E., Weinel C., Paulsen I.T., Dodson R.J., Hilbert H.,
RA   Martins dos Santos V.A.P., Fouts D.E., Gill S.R., Pop M., Holmes M.,
RA   Brinkac L.M., Beanan M.J., DeBoy R.T., Daugherty S.C., Kolonay J.F.,
RA   Madupu R., Nelson W.C., White O., Peterson J.D., Khouri H.M., Hance I.,
RA   Chris Lee P., Holtzapple E.K., Scanlan D., Tran K., Moazzez A.,
RA   Utterback T.R., Rizzo M., Lee K., Kosack D., Moestl D., Wedler H.,
RA   Lauber J., Stjepandic D., Hoheisel J., Straetz M., Heim S., Kiewitz C.,
RA   Eisen J.A., Timmis K.N., Duesterhoeft A., Tuemmler B., Fraser C.M.;
RT   "Complete genome sequence and comparative analysis of the metabolically
RT   versatile Pseudomonas putida KT2440.";
RL   Environ. Microbiol. 4:799-808(2002).
RN   [2]
RP   FUNCTION, SUBUNIT, AND DISRUPTION PHENOTYPE.
RC   STRAIN=ATCC 47054 / DSM 6125 / CFBP 8728 / NCIMB 11950 / KT2440;
RX   PubMed=28620365; DOI=10.3389/fmicb.2017.00990;
RA   Fernandez M., Matilla M.A., Ortega A., Krell T.;
RT   "Metabolic value chemoattractants are preferentially recognized at broad
RT   ligand range chemoreceptor of Pseudomonas putida KT2440.";
RL   Front. Microbiol. 8:990-990(2017).
RN   [3] {ECO:0007744|PDB:6S18, ECO:0007744|PDB:6S1A, ECO:0007744|PDB:6S33, ECO:0007744|PDB:6S37, ECO:0007744|PDB:6S38, ECO:0007744|PDB:6S3B}
RP   X-RAY CRYSTALLOGRAPHY (1.56 ANGSTROMS) OF 47-190 OF APOPROTEIN AND IN
RP   COMPLEXES WITH PROTOCATECHUATE; QUINATE; BENZOATE AND 2-HYDROXYBENZOIC
RP   ACID, DOMAIN, AND MUTAGENESIS OF ARG-71; SER-73; ASN-75; SER-78; GLN-142
RP   AND ASN-158.
RX   PubMed=33021055; DOI=10.1111/febs.15580;
RA   Gavira J.A., Matilla M.A., Fernandez M., Krell T.;
RT   "The structural basis for signal promiscuity in a bacterial
RT   chemoreceptor.";
RL   FEBS J. 288:2294-2310(2021).
CC   -!- FUNCTION: Chemotactic-signal transducers respond to changes in the
CC       concentration of attractants and repellents in the environment,
CC       transduce a signal from the outside to the inside of the cell, and
CC       facilitate sensory adaptation through the variation of the level of
CC       methylation (Probable). PcaY recognizes a wide range of compounds
CC       containing a C6-membered ring with a carboxylate group. Binds
CC       preferentially compounds that serve as carbon sources and among them
CC       those that rapidly promote growth. Tightest binding compounds are
CC       quinate, shikimate, 3-dehydroshikimate and protocatechuate, which are
CC       at the interception of the biosynthetic shikimate and catabolic quinate
CC       pathways (PubMed:28620365). {ECO:0000269|PubMed:28620365, ECO:0000305}.
CC   -!- SUBUNIT: Ligand free PcaY_PP-ligand-binding domain (LBD) is present in
CC       a monomer-dimer equilibrium (PubMed:28620365). Only the dimeric LBD is
CC       able to bind ligands which in turn causes dimer stabilization
CC       (PubMed:28620365). {ECO:0000269|PubMed:28620365}.
CC   -!- SUBCELLULAR LOCATION: Cell inner membrane {ECO:0000305}; Multi-pass
CC       membrane protein {ECO:0000255}.
CC   -!- DOMAIN: The ligand-binding domain (LBD) forms a four-helix bundle
CC       (4HB), and both ligand binding sites of the dimer are occupied with the
CC       high-affinity ligands protocatechuate and quinate, whereas the lower-
CC       affinity ligands benzoate and salicylate are present in only one site.
CC       Ligand binding causes rigid-body scissoring movements of both monomers
CC       of the dimer. {ECO:0000269|PubMed:33021055}.
CC   -!- DISRUPTION PHENOTYPE: Disruption of the gene abolishes chemotaxis to
CC       benzoate, quinate, protocatechuate and shikimate. Inactivation of the
CC       gene does not alter competitive plant root colonization.
CC       {ECO:0000269|PubMed:28620365}.
CC   -!- SIMILARITY: Belongs to the methyl-accepting chemotaxis (MCP) protein
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AE015451; AAN68251.1; -; Genomic_DNA.
DR   RefSeq; NP_744787.1; NC_002947.4.
DR   PDB; 6S18; X-ray; 1.60 A; A/B=1-550.
DR   PDB; 6S1A; X-ray; 2.11 A; A/B=1-550.
DR   PDB; 6S33; X-ray; 1.56 A; A/B=1-550.
DR   PDB; 6S37; X-ray; 2.30 A; A/B=1-550.
DR   PDB; 6S38; X-ray; 2.15 A; A/B=1-550.
DR   PDB; 6S3B; X-ray; 1.95 A; A/B=1-550.
DR   PDBsum; 6S18; -.
DR   PDBsum; 6S1A; -.
DR   PDBsum; 6S33; -.
DR   PDBsum; 6S37; -.
DR   PDBsum; 6S38; -.
DR   PDBsum; 6S3B; -.
DR   AlphaFoldDB; Q88JK6; -.
DR   SMR; Q88JK6; -.
DR   STRING; 160488.PP_2643; -.
DR   PaxDb; 160488-PP_2643; -.
DR   KEGG; ppu:PP_2643; -.
DR   PATRIC; fig|160488.4.peg.2804; -.
DR   eggNOG; COG0840; Bacteria.
DR   HOGENOM; CLU_000445_107_27_6; -.
DR   OrthoDB; 9781845at2; -.
DR   PhylomeDB; Q88JK6; -.
DR   BioCyc; PPUT160488:G1G01-2824-MONOMER; -.
DR   Proteomes; UP000000556; Chromosome.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; IEA:InterPro.
DR   GO; GO:0006935; P:chemotaxis; IEA:UniProtKB-KW.
DR   GO; GO:0007165; P:signal transduction; IEA:UniProtKB-KW.
DR   CDD; cd06225; HAMP; 1.
DR   CDD; cd11386; MCP_signal; 1.
DR   FunFam; 1.10.287.950:FF:000001; Methyl-accepting chemotaxis sensory transducer; 1.
DR   Gene3D; 1.10.287.950; Methyl-accepting chemotaxis protein; 1.
DR   InterPro; IPR004090; Chemotax_Me-accpt_rcpt.
DR   InterPro; IPR003660; HAMP_dom.
DR   InterPro; IPR004089; MCPsignal_dom.
DR   InterPro; IPR003122; Tar_rcpt_lig-bd.
DR   PANTHER; PTHR32089; METHYL-ACCEPTING CHEMOTAXIS PROTEIN MCPB; 1.
DR   PANTHER; PTHR32089:SF120; METHYL-ACCEPTING CHEMOTAXIS PROTEIN TLPQ; 1.
DR   Pfam; PF00672; HAMP; 1.
DR   Pfam; PF00015; MCPsignal; 1.
DR   Pfam; PF02203; TarH; 1.
DR   PRINTS; PR00260; CHEMTRNSDUCR.
DR   SMART; SM00304; HAMP; 1.
DR   SMART; SM00283; MA; 1.
DR   SUPFAM; SSF58104; Methyl-accepting chemotaxis protein (MCP) signaling domain; 1.
DR   PROSITE; PS50111; CHEMOTAXIS_TRANSDUC_2; 1.
DR   PROSITE; PS50885; HAMP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell inner membrane; Cell membrane; Chemotaxis; Membrane;
KW   Methylation; Reference proteome; Transducer; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..550
FT                   /note="Methyl-accepting chemotaxis protein PcaY"
FT                   /id="PRO_0000454714"
FT   TOPO_DOM        1..19
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        20..40
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        41..198
FT                   /note="Periplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        199..219
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        220..550
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          221..273
FT                   /note="HAMP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00102"
FT   DOMAIN          278..514
FT                   /note="Methyl-accepting transducer"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00284"
FT   REGION          44..196
FT                   /note="Ligand-binding domain"
FT                   /evidence="ECO:0000305|PubMed:28620365"
FT   BINDING         71..78
FT                   /ligand="3,4-dihydroxybenzoate"
FT                   /ligand_id="ChEBI:CHEBI:36241"
FT                   /evidence="ECO:0000269|PubMed:33021055,
FT                   ECO:0007744|PDB:6S33"
FT   BINDING         71..78
FT                   /ligand="L-quinate"
FT                   /ligand_id="ChEBI:CHEBI:29751"
FT                   /evidence="ECO:0000269|PubMed:33021055,
FT                   ECO:0000312|PDB:6S38"
FT   BINDING         71
FT                   /ligand="benzoate"
FT                   /ligand_id="ChEBI:CHEBI:16150"
FT                   /evidence="ECO:0000269|PubMed:33021055,
FT                   ECO:0007744|PDB:6S3B"
FT   BINDING         71
FT                   /ligand="salicylate"
FT                   /ligand_id="ChEBI:CHEBI:30762"
FT                   /evidence="ECO:0000269|PubMed:33021055,
FT                   ECO:0007744|PDB:6S37"
FT   BINDING         75
FT                   /ligand="benzoate"
FT                   /ligand_id="ChEBI:CHEBI:16150"
FT                   /evidence="ECO:0000269|PubMed:33021055,
FT                   ECO:0007744|PDB:6S3B"
FT   BINDING         75
FT                   /ligand="salicylate"
FT                   /ligand_id="ChEBI:CHEBI:30762"
FT                   /evidence="ECO:0000269|PubMed:33021055,
FT                   ECO:0007744|PDB:6S37"
FT   BINDING         135
FT                   /ligand="L-quinate"
FT                   /ligand_id="ChEBI:CHEBI:29751"
FT                   /evidence="ECO:0000269|PubMed:33021055,
FT                   ECO:0000312|PDB:6S38"
FT   BINDING         135
FT                   /ligand="salicylate"
FT                   /ligand_id="ChEBI:CHEBI:30762"
FT                   /evidence="ECO:0000269|PubMed:33021055,
FT                   ECO:0007744|PDB:6S37"
FT   BINDING         142
FT                   /ligand="L-quinate"
FT                   /ligand_id="ChEBI:CHEBI:29751"
FT                   /evidence="ECO:0000269|PubMed:33021055,
FT                   ECO:0000312|PDB:6S38"
FT   BINDING         158
FT                   /ligand="L-quinate"
FT                   /ligand_id="ChEBI:CHEBI:29751"
FT                   /evidence="ECO:0000269|PubMed:33021055,
FT                   ECO:0000312|PDB:6S38"
FT   BINDING         169
FT                   /ligand="3,4-dihydroxybenzoate"
FT                   /ligand_id="ChEBI:CHEBI:36241"
FT                   /evidence="ECO:0000269|PubMed:33021055,
FT                   ECO:0007744|PDB:6S33"
FT   MUTAGEN         71
FT                   /note="R->A: Abolishes binding of all ligands."
FT                   /evidence="ECO:0000269|PubMed:33021055"
FT   MUTAGEN         73
FT                   /note="S->A: Abolishes binding of quinate and
FT                   protocatechuate, and shows reduced affinity for benzoate
FT                   and salicylate."
FT                   /evidence="ECO:0000269|PubMed:33021055"
FT   MUTAGEN         75
FT                   /note="N->A: Abolishes binding of benzoate and
FT                   protocatechuate, and shows reduced affinity for quinate and
FT                   salicylate."
FT                   /evidence="ECO:0000269|PubMed:33021055"
FT   MUTAGEN         78
FT                   /note="S->A: Does not significantly alter binding of
FT                   benzoate and protocatechuate."
FT                   /evidence="ECO:0000269|PubMed:33021055"
FT   MUTAGEN         142
FT                   /note="Q->A: Strong decrease in quinate binding and small
FT                   decrease in affinity for salicylate."
FT                   /evidence="ECO:0000269|PubMed:33021055"
FT   MUTAGEN         158
FT                   /note="N->A: Strong decrease in quinate binding and small
FT                   decrease in affinity for salicylate."
FT                   /evidence="ECO:0000269|PubMed:33021055"
FT   HELIX           48..84
FT                   /evidence="ECO:0007829|PDB:6S33"
FT   HELIX           88..115
FT                   /evidence="ECO:0007829|PDB:6S33"
FT   HELIX           119..147
FT                   /evidence="ECO:0007829|PDB:6S33"
FT   HELIX           151..187
FT                   /evidence="ECO:0007829|PDB:6S33"
SQ   SEQUENCE   550 AA;  59486 MW;  2FDCB0C0A7C5431F CRC64;
     MVPTRSTARM LANLKIRTGM FWVLSLFSLT LLFSTASAWW AALGSDQQIT ELDQTAHQSD
     RLNNALLMAI RSSANVSSGF IEQLGGHDES AGKRMALSVE LNNKSQALVD EFVENAREPA
     LRGLATELQA TFAEYAKAVA GQREATRQRS LEQYFKVNSD AGNAMGRLQT LRQQLVTTLS
     ERGQQIMLES DRRLARAQLL SLCLLGVTVV LAVLCWAFIA QRVLHPLREA GGHFRRIASG
     DLSVPVQGQG NNEIGQLFHE LQRMQQSQRD TLGQINNCAR QLDAAATALN AVTEESANNL
     RQQGQELEQA ATAVTEMTTA VEEVARNAIT TSQTTSESNQ LAAQSRRQVS ENIDGTEAMT
     REIQTSSAHL QQLVGQVRDI GKVLEVIRSV SEQTNLLALN AAIEAARAGE AGRGFAVVAD
     EVRTLAYRTQ QSTQEIEQMI GSVQAGTEAA VASMQASTNR AQSTLDVTLA SGQVLEGIYS
     AIGEINERNL VIASAAEEQA QVAREVDRNL LNIRELSNHS AAGAQQTSEA SKALSGLVGE
     MTALVGRFKV
//
